[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100508571":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":39,"responsibleParty":50,"collaborators":25,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":22,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":25,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":79,"overallStatus":80,"whyStopped":25,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Akdeniz University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"DiaPaDeSS intervention group","EXPERIMENTAL","DiaPaDeSS will be introduced to participants with type 2 diabetes during face-to-face interviews. The DiaPaDeSS intervention group will have access to all the contents of the DiaPaDeSS, which includes the patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires. During the follow-up period, the participants in the DiaPaDeSS intervention group will take DiaPaDeSS messages once a week and be reminded to use the education program. The DiaPaDeSS will be asked to use it for three months on daily and weekly inputs. During the follow-up period, the participants can contact the researcher via 24\u002F7 on the DiaPaDeSS. Participants in the DiaPaDeSS intervention group will also receive routine patient education and hospital follow-ups.",[13],"Behavioral: DiaPaDeSS",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","ACTIVE_COMPARATOR","DiaPaDeSS will be introduced to participants with type 2 diabetes in the control group during face-to-face interviews. The control group will have access to only these fields self-management practice tasks (daily, weekly, quarterly), and measurements questionnaires. The diabetes patient education brochure of the Ministry of Health will be sent to the phones of the active control group in pdf format. Participants in the DiaPaDeSS group will also receive routine patient education and routine hospital follow-up during the three-month follow-up period..",[13],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","DiaPaDeSS","Web-based mobile health application for patients with type 2 diabetes (the patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires)",[9],null,{"type":21,"name":22,"description":27,"armGroupLabels":28,"otherNames":25},"Web-based mobile health application for patients with type 2 diabetes (only self-management practice tasks (daily, weekly, quarterly), and measurements questionnaires. The diabetes patient education brochure of the Ministry of Health will be sent to the phones of the active control group in pdf format.)",[15],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Merve YUKSEL, MSc","CONTACT","+90 507 770 01 47","merveyuksel@akdeniz.edu.tr",{"name":36,"role":32,"phone":37,"phoneExt":25,"email":38},"Hicran BEKTAS, Ph.D., RN","+90 242 3106116","hbaydin@akdeniz.edu.tr",[40],{"facility":5,"status":25,"city":41,"state":25,"zip":42,"country":43,"countryCode":25,"cosmosGeoPoint":44,"geoPoint":49,"contacts":25},"Antalya","07070","Turkey (Türkiye)",{"type":45,"coordinates":46},"Point",[47,48],30.69556,36.90812,{"lat":48,"lon":47},{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Merve Yuksel","Research Assistant","100508571","electronic-patient-decision-support-system-for-patients-with-type-2-diabetes-diapadess-100508571",false,"NCT05902156","Electronic Patient Decision Support System for Patients with Type 2 Diabetes (DiaPaDeSS)","The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters","Inclusion Criteria:\n\n* Patients with type 2 diabetes who had been followed up and treated at the Endocrinology and Metabolic Diseases Polyclinic\n* Aged between 18-65 years\n* Patients who know their diagnosis and can verbally express it\n* Have been diagnosed with type 2 diabetes for at least six months\n* Who are literate\n* Who have internet access at home, who have one of the tools such as a computer, tablet or smartphone and can use these tools\n* Consented to participate in the study\n* Had no other psychiatric or mental barriers to answering the questions, language or cognitive difficulties, and barriers to verbal or written communication\n\nExclusion Criteria:\n\n* Diagnosed with myocardial infarction, stroke or diabetic foot in the last six months\n* Diagnosed with type 1 diabetes or gestational diabetes\n* Diagnosed with terminal illness\n* Using steroid therapy\n* Had pregnant\n* Having dementia and cognitive deficits\n* Having retinopathy or advanced neuropathy\n* Patients whose information is not allowed to be accessed","ALL","18 Years","65 Years",{"count":65,"type":66},72,"ESTIMATED","INTERVENTIONAL",[69],"NA","This study evaluates the effects of an electronic patient decision support system developed for the use of patients with type 2 diabetes (DiaPaDeSS) on self-management, patient activation, and metabolic parameters. To manage type 2 diabetes after discharge, patients must continue to perform interventions at home, such as blood glucose monitoring, blood pressure measurement, weight measurement, medication use, and foot care. To achieve this, patient's self-management and activation levels should be increased. This can also lead to positive improvements in the metabolic parameters. It would be beneficial to develop DiaPaDeSS that can increase the self-management and activation levels of patients with type 2 diabetes. The investigators will develop the DiaPaDeSS intervention protocol. Our content includes patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), a type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires. The content of the DiaPaDeSS will be evaluated by 10 experts in the fields of medicine, nursing, and informatics. A feasibility test with seven patients will be conducted to evaluate the usability of DiaPaDeSS. A single-blind, randomized controlled trial design will be used. Patients with type 2 diabetes will be pretested and randomized (intervention 36, control 36) to the DiaPaDeSS intervention and control groups. Both the DiaPaDeSS intervention and control groups will use the DiaPaDeSS for three months. While participants in the DiaPaDeSS intervention group can reach all contents of the DiaPaDeSS, others can reach only these fields: self-management practice tasks (daily, weekly, quarterly), and measurements questionnaires. The effectiveness of the DiaPaDeSS will be evaluated at baseline and at month 3.",[72,73,74,75,76,77,78],"Mobile Health","Type 2 Diabetes","Patient Activation","Self-Management","Decision Support System","Nursing","Randomized Controlled Trial",[72,73,74,76,75,77,78],"NOT_YET_RECRUITING","2025-02-04",{"date":83,"type":84},"2025-02-06","ACTUAL",{"date":86,"type":66},"2025-03-30",{"date":88,"type":66},"2025-11-01",{"name":5,"class":6},1]